Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I am down to a .97 average so in it like Artal with their $1 buys. Big win or big loss, my ship has sailed too.
I sense a deal coming that takes a company that is in this space/market and merges/buys out these rocket scientists to get on the exchange. I am stuck one way or another and going to wait it out. Just my foolish opinion. They have not even posted when they will discuss earnings and it should be happening any day now.
Is biotech sorghum a noxious weed?
http://www.agprofessional.com/news/biotech-sorghum-noxious-weed
Word filtered from U.S. Department of Agriculture sources is that a genetically modified sorghum developed for use in cellulosic ethanol might be classified as a noxious weed, which would restrict its planting.
Ceres Inc., a biotech research and development company, developed the sorghum, which has been shown to grow a large mass of vegetation. Apparently because the company used genetic material from a noxious weed along with various sorghum plants, the USDA is looking at the new sorghum as a potential noxious weed, too.
Discussion about the sorghum is ongoing. According to Capital Press, “Ceres’ biotech cultivar ‘produces greater biomass and contains more fermentable sugars than non-genetically modified sorghum checks, thereby offering a higher yield potential,’ the company said in a letter requesting regulatory clarity form USDA.”
The USDA is not looking at the sorghum as a plant pest, which is generally defined as viruses, bacteria or fungi that can cause disease with a plant. The noxious weed definition is generally referred to as plants that damage crops or livestock.
Ceres could use a positive resolution of the situation to possibly help its financial situation. The most recent financial report showed the company struggling financially and its stock in an extremely bearish position.
While I am at it, another interesting one. Normally a patent application is not published until 18 months after the earliest date. On Jan 1st one was published that was applied for in Sept. 2014. According to the guidelines it can be done early at the request of the applicant, why? Schneeberger is the Director of Core Research and Development / Renewable Energy
NexSteppe, a competitor, but used to work at Ceres but left years before the patent was filed from what is on the net. Is something up between the two companies? Going way out on a limb here, but I have a feeling there will be more to come on this. Parallel paths colliding maybe?
PUBLICATION.—
(1) IN GENERAL.—
(A) Subject to paragraph (2), each application for a patent shall be published, in accordance with procedures determined by the Director, promptly after the expiration of a period of 18 months from the earliest filing date for which a benefit is sought under this title. At the request of the applicant, an application may be published earlier than the end of such 18-month period.
My question would be whats so important that they wanted this in the public eye vs. 18 months??? Mumbo jumbo to me, but a curious thing.
SCHNEEBERGER; Richard ; et al. January 1, 2015
PROMOTER, PROMOTER CONTROL ELEMENTS, AND COMBINATIONS, AND USES THEREOF
Abstract
The present invention is directed to promoter sequences and promoter control elements, polynucleotide constructs comprising the promoters and control elements, and methods of identifying the promoters, control elements, or fragments thereof. The invention further relates to the use of the present promoters or promoter control elements to modulate transcript levels in plants, and plants containing such promoters or promoter control elements.
Inventors: SCHNEEBERGER; Richard; (Carlsbad, CA) ; MARGOLLES-CLARK; Emilio; (Miami, FL) ; TATARINOVA; Tatiana; (Los Angeles, CA) ; FANG; Yiwen; (Redondo Beach, CA) ; ALEXANDROV; Nickolai; (Thousand Oaks, CA) ; MEDRANO; Leonard; (Azusa, CA) ; PENNELL; Roger; (Malibu, CA) ; THEISS; Noah; (Tucson, AZ) ; GRIZARD; Danielle; (Moorpark, CA) ; DAVIS; Shauna J.; (College Station, TX) ; ROBLES; Dennis; (Chatsworth, CA) ; PORTEREIKO; Michael; (Thousand Oaks, CA)
Applicant:
Name City State Country Type
CERES, INC.
Thousand Oaks
CA
US
Family ID: 1000000726930
Appl. No.: 14/476566
Filed: September 3, 2014
and then the EPA says that Sorghum has good potential as a bio-fuel, go figure that the agencies don't see things the same. Tax dollars of ours at work...
http://biomassmagazine.com/articles/11389/epa-accepting-comments-on-preliminary-biomass-sorghum-analysis
Whoops, sorry posted today.... http://www.capitalpress.com/Research/20150105/biotech-energy-crop-may-be-regulated-as-weed
Leave it to the government to "protect" us.. or is it the other fuel producers they want to watch out for since it is so good?
WTF???
Ceres Inc. has developed a biotech variety of sorghum for ethanol production but USDA is thinking of regulating it as a noxious weed.
Genetically modified sorghum used for ethanol production doesn’t fall under USDA’s biotechnology regulations, but the agency may still restrict the crop as a noxious weed.
Ceres Inc., a biotech company, inserted genetic information from several sources into the sorghum variety using a “gene gun,” avoiding the use of a soil pathogen to transfer genes.
The USDA has agreed that the genetically engineered sorghum isn’t a potential plant pest and thus cannot be restricted on that basis, but the agency has nonetheless considering regulating the crop as a noxious weed and “will discuss that subject in a separate communication,” according to a letter recently disclosed to the public.
Plant pests are viruses, bacteria or fungi that can cause disease within the plant, while noxious weeds are defined more generally as plants that damage crops or livestock.
Ceres’ biotech cultivar “produces greater biomass and contains more fermentable sugars than non-genetically modified sorghum checks, thereby offering a higher yield potential,” the company said in a letter requesting regulatory clarity from USDA.
It was transformed with synthetic genetic material and genes from mouse ear cress, which is considered a mustard weed, as well as other sorghum plants, the company said.
Capital Press was unable to reach Ceres for comment.
Ceres already has sorghum varieties available for sale, but the company is struggling financially, according to documents submitted to the U.S. Securities and Exchange Commission.
In its 2014 fiscal year, the company’s product sales dropped to $146,000, down nearly 70 percent from the previous year, which the company attributes to “changes and reductions in our sales incentive and promotional programs,” Ceres said in a regulatory filing.
Revenue from collaborative research and government grants fell by more than half, to $2.26 million, as Ceres completed various projects, the document said.
Ceres’ overall income was surpassed by the cost of product sales, research costs and administrative expenses, resulting in more than $29 million in losses in fiscal 2014, according to the documents.
Since the company raised $65 million with an initial public offering of its stock in early 2012, its share price has dropped from about $15 to less than 25 cents.
So here is an interesting twist. Ceres holds the trademark on ORIGEN and when the former VP of operations left, Mike Stephenson, he went to a company called ORIGEN Seed technologies nearby to be the president. Kinda strange if you ask me. There seems to be little information on the company and why would an ex employee start or work for a company that is named after a trademark his old company had? Kinda weird, note the unique spelling of ORIGEN is common.
On October 11, 2013, we and Mr. Stephenson mutually agreed to end his employment effective January 10, 2014.
Yet now:
President
Origen Seed Technologies
January 2014 – Present (1 year 1 month)Camarillo, California
Origen Seed Technologies is a agricultural seed companies offering hybrid corn and soybeans in the southern U.S.
anyhow, back to the platform and waiting on the train.
It's earnings week and hopefully it is not the same old same old. There needs to be some excitement rather than the hum drum of seeds are are growing and we are a plantin.
Headlines like this should help:
EPA backs sorghum as low-carbon cellulosic fuel under RFS
Tired of waiting for the train to leave the station.
The rhyme I would like to hear is .
The CEO is buying,
I'm not crying!
Or
The CEO is buying,
This stock is not dying!
Formality I agree, so lets see what they have in the pipeline to avoid it. All for it and in for the long term.
Oh Well...
PROPOSAL 2: APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO EFFECT A REVERSE SPLIT OF OUR OUTSTANDING COMMON STOCK AT THE DISCRETION OF THE BOARD OF DIRECTORS
Summary
Our Board of Directors has unanimously approved a proposal to effect a reverse split of all of our outstanding shares of Common Stock by a ratio in the range of 1-for-8 and 1-for-11. The proposal provides that our Board of Directors shall have sole discretion pursuant to Section 242(c) of the Delaware General Corporation Law to elect, as it determines to be in the Company’s best interest, whether or not to effect the reverse stock split before April 27, 2015, such date as the Company is required to comply with the minimum bid price requirements of NASDAQ Listing Rule 5550(a)(2) or to abandon it. Should the Board of Directors proceed with a reverse stock split, the exact ratio shall be set at a whole number within the above range as determined by our Board of Directors in its sole discretion. Our Board of Directors believes that the availability of alternative reverse stock split ratios will provide it with the flexibility to implement the reverse stock split in a manner designed to maximize the anticipated benefits for the Company and its stockholders. In determining whether to implement the reverse split following the receipt of stockholder approval, our Board of Directors may consider, among other things, factors such as:
Would be happy to see it move off of the below cash pps that we are at to a better place.
We can't even get a good rumor going for this. Boring scientists at work I guess and hope.
You would think he would have the money to buy in at these low prices. Troublesome for sure and if there was some insider buys now it sure would move the price imo
Agree completely, suspicious for sure and what I find different than most stock in this area is the total silence from the company period.
Agree completely, suspicious for sure and what I find different than most stock in this area is the total silence from the company period.
Me too, lets report them for not reporting anything to make the stock shoot up as far as its fallen down
Ceres Announces Changes to Board of Directors
THOUSAND OAKS, Calif., Dec. 15, 2014 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology and seed company, announced today that Aflalo Guimaraes has joined its board of directors. Mr. Guimaraes succeeds Raymond Debbane, who retired from Ceres' board.
"Mr. Debbane, who was nominated to the Ceres board by Artal Luxembourg, our largest stockholder, has been a steadfast proponent of our technology and intellectual property portfolio, and we have appreciated his support and service to our board as we moved ahead with the advancement and commercialization of our seed products, traits and genomic technologies. We look forward to working with Mr. Guimaraes, who brings extensive financial and business expertise to our board," said Ceres President and CEO Richard Hamilton.
Aflalo Guimaraes is a managing director of The Invus Group, LLC, an affiliate of Artal Luxembourg S.A. Prior to joining Invus in 1998, he was a manager at Marakon Associates where he led strategic consulting engagements for large multi-national companies in a wide range of industries, including financial services, retail and consumer products. He previously worked at the U.S. Federal Reserve. Mr. Guimaraes holds an MBA from the University of Pennsylvania's Wharton School and a BA in Economics and Political Science from Yale University. He currently serves on the boards and audit committees of a number of private companies.
Seems to be the case, no real pumpers or dumpers posting on any of the boards around. zero on the radar scale. Lots of volume today though.
Amazing the difference a year can make.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=93942762
Is this anything important? Had not seen nor heard of this, or just missed it amongst all the news released. :(
http://www.lsuagcenter.com/en/crops_livestock/crops/bioenergy/biofuels_bioprocessing/subi/multimedia/economic/calculate-your-footprint.htm
and
http://www.lsuagcenter.com/en/crops_livestock/crops/bioenergy/biofuels_bioprocessing/subi/about_subi/welcometosubi.htm
and
http://www.lsuagcenter.com/en/crops_livestock/crops/Bioenergy/biofuels_bioprocessing/subi/plant/MillingEnergycaneandSweetSorghum.htm
I kinda expect this for a while...http://assets.nerdwallet.com/blog/travel/files/2012/09/Behemoth.jpg
not even a .001 yet in the plus direction....lol
Yippee - $2-$4...is the campaign beginning to get the word out?
Ceres Inc (NASDAQ:CERE) stock has received a short term price target of $ 3 from 2 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $1.41. The higher estimate of target price is $4 , while the lower price target estimate is $2 Ceres Inc (NASDAQ:CERE) : Strong bullish mood helped the shares of Ceres Inc (NASDAQ:CERE) appreciate in value. The share price gained 0.007 points or 2.56% to close at $0.28 with 242,214 shares exchanging hands. The trading began on a bullish sentiment but no considerable downsides were seen throughout the day; the intraday low was registered at $0.2534. However, the shares hit an intraday high of $0.287. The previous close of the share price was $0.273. Ceres Inc (NASDAQ:CERE) has a market cap of $14 million and the number of outstanding shares is calculated to be 48,266,000. The 52-week low of the share price is $0.22.
http://www.marketsinsider.com/company-price-targetsceres-inc-black-diamond/320171/
Who knows anymore, have a good holiday all and lets see if we get a xmas present in the next month.
I am beginning to think they might want to dry up what little shares there really are by the RS. In the CC there was the monotone "let the market decide" attitude in one breath and in another they are discussing all of the things coming up. A RS would do that and pave the way for an equity partner like you say. Licensing their IP was another revenue stream if they really do it along with all the rest. China could be a big one too, no shortage of people there. The list of upcoming things goes on as we know. Maybe they will slip up and tweet their intentions :)
One thing for sure there is no outward enthusiasm displayed in any release they come up with, bunch of scientists at work I guess.
Slowly adding to the retirement account and sooner or later we will find out what Mr. Debbane has up his sleeve. Personally I can't see him sitting idle for all this and letting his investment go poof.
Fair and Balanced as they say....
http://www.pacbiztimes.com/2014/11/21/ceres-still-spending-but-looks-to-generate-revenue/
Ceres encourages resale known Blade GrandSilo
Ceres Seeds Brazil started in the last days an incentive campaign aimed to resellers of agricultural products from all over Brazil. The company wants to encourage these distributors to meet hybrid sorghum silage Blade GrandSilo BD1615 brand, for the production-based feed for beef cattle and milk. The product has just been released in the packaging of 10 kg.
According to Ceres, which owns one of the largest banks in the world sorghum germplasm, this November starts the ideal for cultivation of Blade® GrandSilo BD1615. The recommendation of the company is to carry out planting to December 20. With the incentive campaign, Ceres wants to expand its distribution network and form business partnerships around the new product.
Previous studies the launch of hybrid Blade GrandSilo BD1615 revealed their excellent agronomic performance and high productivity in the field. The yield ranged between 40 and 60 tons of green matter per hectare with 30% dry matter, reaching up to 84 tons per hectare, depending on the region.
Agricultural San Francisco tested GrandSilo® BD1615
Present among the 30 best companies in Brazil in its segment, according to Assocon - National Association of Feedlot -, Agriculture San Francisco, of Goiatuba (GO), tested the sorghum hybrid Blade GrandSilo BD1615. On the property are confined approximately 15,000 units per year. The manager of San Francisco, Osvaldo Pereira de Souza, attests good results with the product.
"We have proven the efficiency and quality of the material. Cultivate GrandSilo and found that the plant had great health. The cost was lower than if we had planted corn for silage, "says Pereira de Souza.
According to the manager, the process of fermentation of sorghum GrandSilo "was a bit faster than corn silage." This, says the professional, is another important benefit, "because we can use faster in animal nutrition," he adds.
According to Pereira de Souza, the animals showed good acceptance by power from sorghum GrandSilo, no change in the volume of consumption in comparison with corn silage used previously. "Consumption of original material remained unchanged. I point out the GrandSilo exactly why these differentials. The product results in high productivity with a lower cost and good acceptance in the trough, "says. "Not only will we repeat the cultivation how to plant a larger area sooner," concludes the San Francisco manager.
Translated from http://www.grupocultivar.com.br/site/content/noticias/?q=41749
That's what I am thinkin and hopin for! Time for the gate to open and let this run in the right direction for once.
Agree on that.
The Water Warriors: 12 Hot Drought-Fighters in the advanced bioeconomy..
Don't recall seeing this, interesting and Ceres in China could be the catalyst along with SaaS. They have been lightly mentioning it here and there.
http://www.biofuelsdigest.com/bdigest/2014/08/17/the-water-warriors-12-hot-drought-fighters-in-the-advanced-bioeconomy/
I would hope that Artal ratchets up the pressure to get the word out a bit more. April is not that far off and there seems to be good things in the pipe and CERE is not publicity minded IMO. A bunch of scientists with a real lack of marketing skills and it is evident by it trading at less than cash. Don't need a press release for every time the CEO sneezes, but it would help get the word out, unless they do not want anyone to know. Also some buying by management would be a plus. If they really believed in the company and stock they should peel out the wallet and make some market buys. It still bugs me that they sit and watch it drop and drop without adding to their own portfolio.
Let's see if Artal puts its weight into the game more visibly and not sit idle as their investment sinks.
Funny how articles spin things. Earnings missed but revenues exceeded by quite a bit 1.1M, yet it is all negative in the local news. Ceres must have pissed off the reporter at some point.
Energy crop developer Ceres Inc. on Thursday reported annual losses that exceeded analyst estimates, as the company continues to struggle
The Thousand Oaks company reported a net loss of $29.3 million (-81 cents a share) for its fiscal year ended Aug. 31, compared with a loss of $32.5 million (-$1.31) in the previous year. Revenue fell 54 percent to $2.4 million.
Analysts on average expected a net loss of 61 cents on revenue of $1.3 million, according to Thomson Financial Network.
Ceres has struggled to find a market for its genetically engineered sweet sorghum seeds to make ethanol in Brazil. Sales have been lower than expected, and the company has not announced a profit since going public in 2012.
However, the company said in its earnings report that ethanol yields from the season were 35 percent higher on average than the previous season.
Shares closed down a penny to 28 cents on the Nasdaq.
http://sfvbj.com/news/2014/nov/20/briefs-tutor-perini-wesco-ceres/
And then at SeekingAlpha they put it this way.
Ceres misses by $0.20, beats on revenue
Nov 20 2014, 16:11 ET | By: Mohit Manghnani, SA News Editor
Ceres (NASDAQ:CERE): FY EPS of -$0.81 misses by $0.20.
Revenue of $2.4M (-54.2% Y/Y) beats by $1.1M.
Shares +14.3%.
I agree and it is coming together. Happy with the call and the progress is moving forward. GLTA and can't wait for 2015
THOUSAND OAKS, Calif., Nov. 20, 2014 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology and seed company, announced today financial results for the fiscal year ended August 31, 2014 and provided an update on its business.
For the 2014-2015 sorghum growing season in Brazil, the company reported that total plantings of its sorghum products are expected to cover up to approximately 5,000 hectares, compared to approximately 1,000 hectares planted the previous season. The increase in planted area is due primarily to increased demand for high biomass sorghum for power generation.
During the previous 2013-2014 growing season in Brazil, Ceres achieved yield targets of 2,500 to 3,000 liters per hectare for its sweet sorghum with multiple products in multiple regions. Average yields were 35% higher than the previous year, according to company calculations. Similarly, the company believes that a number of its high biomass sorghum hybrids met or exceeded minimum yield levels needed for commercialization. Ceres expects that the 2014-2015 growing season in Brazil will be necessary to validate these positive results. This season, the company also initiated sales of its sorghum for use in the forage feed market, following successful evaluations in the U.S. and Brazil.
Ceres President and CEO Richard Hamilton said that the company intends to use larger plantings this season to help establish sorghum as an integral part of the energy and fuel matrix in Brazil. "Our goal is to confirm last season's performance gains as we continue to convert field evaluations into commercial-scale plantings," he said.
Outside of the bioenergy industry, which is facing pressures from lower petroleum prices, Hamilton said that the company is expanding into additional markets for its seeds, traits and technology. "We are especially interested in food and feed crops, like sugarcane and forage sorghum, where we can leverage our existing capabilities in traits and breeding for markets driven by global growth trends in meat, dairy and sugar consumption, and where our capabilities and technology can provide us with a competitive advantage," he said. Leveraging its historical expertise in genomics and bioinformatics, the company also is pursuing opportunities in the bioinformatics software market, where growth is being driven by low-cost DNA sequencing.
Ceres Chief Financial Officer Paul Kuc reported that expenses for the fiscal year ended August 31, 2014 were in line with management's expectations. "We continue to direct our capital resources to areas of the business that can provide immediate and near-term returns, and which provide us opportunities for long-term revenue generation and growth," said Kuc.
Business Highlights and Outlook
In July, Ceres' Brazilian subsidiary was selected for a competitive grant and a multi-year credit facility under Brazil's PAISS Agricola program to fund a product development project for sorghum and sugarcane for up to approximately 85 million reais (US$34 million). The project consists of a non-repayable grant of up to approximately 10 million reais (US$4 million) and a government-subsidized credit facility for up to approximately 67.5 million reais (US$27 million). The company is expected to fund up to approximately 7.5 million reais (US$3 million) of the project. Ceres has completed the required application and received approval in principle for the grant and credit facility. Subject to the completion of customary documentation and financial guarantees to be provided by Ceres, the company expects to draw the first tranche of the non-repayable grant during its second fiscal quarter and the first tranche of the credit facility during its third fiscal quarter. Ceres said the funding will extend its capital resources, while allowing the company to pursue additional opportunities for its biotech traits in sugarcane.
Ceres reported that plantings for the 2014-2015 sorghum growing season in Brazil have commenced and are expected to continue through December. The company expects to evaluate its sorghum products with more than 50 customers, including mill and multi-mill conglomerates that are collectively responsible for more than 30% of the sugarcane crushed in Brazil.
To meet immediate demand for biomass for power generation and to facilitate the development of a supply chain for sorghum biomass, Ceres will provide agronomy and crop management services for customers this season, including customers with limited experience in managing the crop. The sales incentive and promotional programs include offtake agreements for sorghum produced under the company's direction or management. Revenue for these plantings will be based upon yields per hectare rather than seed sales. Ceres expects the majority of its high biomass sorghum hectares this season to be planted under its sales incentive and promotional programs.
Due to similarities among crops developed for bioenergy and those developed for livestock consumption, Ceres believes that certain of its seed products and traits may have additional applications in the hay and forage feed market. Last season, the company completed pilot commercial sales of its seed products, which have demonstrated competitive yield advantages in both company and university trials. For the upcoming growing season, Ceres has established more formal marketing channels of its sorghum hybrids for the hay and forage feed markets in the United States and Brazil.
Ceres reported that one of its leading biotech traits provided a greater than 20% biomass yield advantage in a commercial-type forage sorghum in field evaluations completed this fall in the U.S. The company said it will move the trait into various forage hybrids in preparation for additional field evaluations. Should performance improvements be confirmed at commercial scale, the company believes that hybrids with this trait could provide a significant performance advantage over competitor seed products.
Fiscal Year 2014 Financial Results
Total revenues for the year ended August 31, 2014 were $2.4 million compared to $5.2 million for the previous fiscal year. Collaborative research and government grant revenue decreased by $2.5 million primarily due to the completion of work scheduled under various grants and collaborations and to a lesser extent due to the deferment of certain collaborative research revenue into fiscal year 2015. Product sales decreased by $0.3 million primarily due to reduced biomass sales for the 2013-2014 sorghum growing season in Brazil, which resulted from changes and reductions in the company's sales incentive and promotional programs.
Total cost and operating expenses decreased by $6.2 million to $31.7 million for the year ended August 31, 2014 compared to the previous fiscal year.
Cost of product sales decreased by $3.2 million to $3.0 million for the year ended August 31, 2014 compared to the prior fiscal year. The decrease was primarily due to reduced expenses of $1.7 million resulting from changes and reductions in the company's sales incentive and promotional programs for the 2013-2014 sorghum growing season in Brazil and reduced expenses of $1.5 million related to obsolete seed inventory.
Research and development expenses decreased by $2.2 million to $14.2 million for the year ended August 31, 2014 compared to the previous fiscal year. In the U.S., research and development expenses decreased by $2.6 million primarily due to reduced external research and development expenses as well as reduced personnel and related expenses. In Brazil, research and development expenses increased by $0.4 million primarily as a result of increased personnel and related expenses.
Selling, general and administrative expenses decreased by $0.7 million to $14.5 million for the year ended August 31, 2014 compared to the prior fiscal year. In the U.S., expenses decreased by $1.9 million primarily due to reduced personnel and related expenses and reduced professional fees. Expenses in Brazil increased by $1.2 million as a result of increased expenditures related to establishing and building the company's market presence and business infrastructure.
For the fiscal year ended August 31, 2014, Ceres reported a net loss of $29.3 million, or $0.81 per share, compared to a net loss of $32.5 million, or $1.31 per share, for the fiscal year ended August 31, 2013.
At August 31, 2014, cash and cash equivalents and marketable securities totaled $28.0 million.
Conference Call and Webcast Information
Ceres has scheduled a conference call for 4:30 p.m. EST (1:30 p.m. PST) today to discuss its fiscal year 2014 results and to provide an update on its business. To access the webcast of the conference call, go to investor.ceres.net. Audio of the teleconference is also available by dialing (877) 838-4153 (domestic) or +1(720) 545-0037 (international). The conference ID number is 20834820. An audio replay of the call will be available two hours after the conclusion of the live call, and remain available on the Ceres website for 30 days.
and what should we tell them?